Join
Live feed
·
PRReleasevia Quantisnow
IGM Biosciences Inc. logo

IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development

ByQuantisnow·Wall Street's wire, on your screen.
IGMS· IGM Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IGMS (IGM Biosciences Inc.) and more on Quantisnow.